Business
CareRx Closes Bought Deal Financing and Concurrent Private Placement for Gross Proceeds of $21.2 million
CareRx Closes Bought Deal Financing and Concurrent Private Placement for Gross Proceeds o...
About this update from Carerx Corporation
[{"type":"text","content":"\n \n \n \n CareRx Closes Bought Deal Financing and Concurrent Private Placement for Gross Proceeds of $21.2 million\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN\n \n CANADA\n \n ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO\n \n UNITED STATES\n \n NEWSWIRE SERVICES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n ./\n \n \n \n TORONTO\n \n ,\n \n Feb. 3, 2021\n \n /CNW/ - CareRx Corporation (\"\n \n CareRx\n \n \" or the \"\n \n Company\n \n \") (TSX: CRRX),\n \n Canada's\n \n leading provider of specialty pharmacy services to seniors, is pleased to announce that it has completed its previously announced bought deal public offering (the \"\n \n Offering\n \n \") and concurrent private placement (the \"\n \n Concurrent Private Placement\n \n \") of common shares of the Company (\"\n \n Common Shares\n \n \") for aggregate gross proceeds of approximately\n \n $21.2 million\n \n .\n \n \n The Company issued an aggregate of 3,517,850 Common Shares (the \"\n \n Offering Shares\n \n \") pursuant to the Offering, including 458,850 Offering Shares issued as a result of the exercise in full of the over-allotment option granted to the syndicate of underwriters co-led by Eight Capital and Cormark Securities Inc. and including Beacon Securities Limited, Canaccord Genuity Corp., Stifel Nicolaus Canada Inc., iA Private Wealth Inc., Desjardins Securities Inc. and Leede Jones Gable Inc., at a price of\n \n $4.25\n \n per Offering Share for aggregate gross proceeds of approximately\n \n $14.95 million\n \n .\n \n \n In addition, the Company issued an aggregate of 1,469,411 Common Shares (the \"\n \n Placement Shares\n \n \"), at a price of\n \n $4.25\n \n per Placement Share, pursuant to the Concurrent Private Placement with Yorkville Asset Management Inc., for and on behalf of certain managed funds, and Dr.\n \n Jack Shevel\n \n , each of whom are existing major shareholders of the Company, for aggregate gross proceeds of approximately\n \n $6.25 million\n \n .\n \n \n The net proceeds of...